HOTH News and Press, Hoth Therapeutics Inc. From 09/13/23

2023-09-13 14:16:14 ET Gainers: Avalo Therapeutics ( AVTX ) +56% . ZyVersa Therapeutics ( ZVSA ) +41% . Rocket Pharmaceutical ( RCKT ) +35% . Vigil Neuroscience ( VIGL ) +31% . Aspira Women's Health ( AWH ) +27% . Novo Integr...

Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules PR Newswire NEW YORK , Sept. 13, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced...

2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...

Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia PR Newswire Gastrointestinal Stromal Tumors Cells Rapidly Died Between 48 and 72 Hours After Exposure to HT-KIT. HT-KIT Shows Posit...

Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients PR Newswire HT-KIT received Orphan Drug Designation from FDA for its mRNA Frame Shifting Cancer Therapeutic Hoth intends to initially...

Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa PR Newswire 78% of patients reported that their overall health had improved since starting BioLexa as compared to 22% stating that there was no change in their health, or their he...

2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...

2023-08-09 10:51:01 ET Results from a preclinical study of Hoth Therapeutics' ( NASDAQ: HOTH ) HT-ALZ for Alzheimer's disease found that the candidate led to improvement in areas of cognitive function. More specifically, benefits were seen with spatial learning and memory, sen...

Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease PR Newswire HT-ALZ Showed Improvement on Several Tests of Cognitive Function HT-ALZ Showed Positive Benefits with Reductions in Anxiety Completed Dose Res...

Hoth Therapeutics Announces Major Milestone of First Patient Dosed in Phase 2a Clinical Trial PR Newswire NEW YORK , July 25, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced today that the ...